Literature DB >> 26614146

Pretreatment with remifentanil protects against the reduced-intestinal contractility related to the ischemia and reperfusion injury in rat.

Hale Sayan-Ozacmak1, Veysel Haktan Ozacmak2, Inci Turan1, Figen Barut3, Volkan Hanci4.   

Abstract

BACKGROUND AND OBJECTIVES: Serious functional and structural alterations of gastrointestinal tract are observed in failure of blood supply, leading to gastrointestinal dismotility. Activation of opioid receptors provides cardioprotective effect against ischemia-reperfusion (I/R) injury. The aim of the present study was to determine whether or not remifentanil could reduce I/R injury of small intestine.
METHODS: Male Wistar Albino rats were subjected to mesenteric ischemia (30 min) followed by reperfusion (3h). Four groups were designed: sham control; remifentanil alone; I/R control; and remifentanil+I/R. Animals in remifentanil+I/R group were subjected to infusion of remifentanil (2 ug kg(-1)min(-1)) for 60 min, half of which started before inducing ischemia. Collecting the ileum tissues, evaluation of damage was based on contractile responses to carbachol, levels of lipid peroxidation and neutrophil infiltration, and observation of histopathological features in intestinal tissue.
RESULTS: Following reperfusion, a significant decrease in carbachol-induced contractile response, a remarkable increase in both lipid peroxidation and neutrophil infiltration, and a significant injury in mucosa were observed. An average contractile response of remifentanil+I/R group was significantly different from that of the I/R group. Lipid peroxidation and neutrophil infiltration were also significantly suppressed by the treatment. The tissue samples of the I/R group were grade 4 in histopathological evaluation. In remifentanil+I/R group, on the other hand, the mucosal damage was moderate, staging as grade 1.
CONCLUSIONS: The pretreatment with remifentanil can attenuate the intestinal I/R injury at a remarkable degree possibly by lowering lipid peroxidation and leukocyte infiltration.
Copyright © 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Contratilidade intestinal; Intestinal contractility; Intestinal ischemia–reperfusion injury; Lesão intestinal de isquemia/reperfusão; Rat; Rato; Remifentanil

Mesh:

Substances:

Year:  2014        PMID: 26614146     DOI: 10.1016/j.bjane.2013.09.007

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  3 in total

1.  Remifentanil Promotes PDIA3 Expression by Activating p38MAPK to Inhibit Intestinal Ischemia/Reperfusion-Induced Oxidative and Endoplasmic Reticulum Stress.

Authors:  Jiantong Shen; Yaqing Zhan; Qiulan He; Qiwen Deng; Kunhe Li; Shihong Wen; Wenqi Huang
Journal:  Front Cell Dev Biol       Date:  2022-01-26

2.  Impact of intravenous dexmedetomidine on gastrointestinal function recovery after laparoscopic hysteromyomectomy: a randomized clinical trial.

Authors:  Yu Wu; Zenghua Cai; Lishuang Liu; Jinbao Wang; Yanli Li; Yuling Kang; Ni An
Journal:  Sci Rep       Date:  2022-08-27       Impact factor: 4.996

3.  Effects of remifentanil with or without midazolam pretreatment on the 95% effective dose of propofol for loss of consciousness during induction: A randomized, clinical trial.

Authors:  Jae Chul Koh; Juyeon Park; Na Young Kim; Ann Hee You; Seo Hee Ko; Dong Woo Han
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.